Carole Bourquin

6.7k total citations · 2 hit papers
78 papers, 4.8k citations indexed

About

Carole Bourquin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Carole Bourquin has authored 78 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 22 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Carole Bourquin's work include Immunotherapy and Immune Responses (34 papers), Immune Cell Function and Interaction (28 papers) and Immune Response and Inflammation (24 papers). Carole Bourquin is often cited by papers focused on Immunotherapy and Immune Responses (34 papers), Immune Cell Function and Interaction (28 papers) and Immune Response and Inflammation (24 papers). Carole Bourquin collaborates with scholars based in Switzerland, Germany and United States. Carole Bourquin's co-authors include Stefan Endres, Gunther Hartmann, David Anz, Veit Hornung, Nadja Sandholzer, Andrea Ablasser, Martin Schlee, Thibaud Spinetti, Anne M. Noronha and Muthiah Manoharan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Blood.

In The Last Decade

Carole Bourquin

76 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7

2005 967 citations Veit Hornung, Carole Bourquin et al. profile →
Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome Activation

2013 605 citations Yiqing Yan, Wei Jiang et al. Immunity profile →

Peers

Countries citing papers authored by Carole Bourquin

Since Specialization

Citations

This map shows the geographic impact of Carole Bourquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Bourquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Bourquin more than expected).

Fields of papers citing papers by Carole Bourquin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Bourquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Bourquin. The network helps show where Carole Bourquin may publish in the future.

Co-authorship network of co-authors of Carole Bourquin

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Bourquin. A scholar is included among the top collaborators of Carole Bourquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Bourquin. Carole Bourquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma 2025 ·JCI Insight ·(unknown), (unknown), (unknown), Maxime Borgeaud, Montserrat Alvarez, (unknown), Olivier Preynat‐Seauve, (unknown), Eliana Marinari, Denis Migliorini, Valérie Dutoit, Carole Bourquin, Aurélien Pommier	1
2	Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell function 2025 ·Cell Death Discovery ·(unknown), (unknown), (unknown), (unknown), (unknown), Shozeb Haider, Carole Bourquin, Philìppe Bertrand, Muriel Cuendet	0
3	Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer 2024 ·Cancer Cell International ·Alyaa Dawoud, R.A. Youness, (unknown), (unknown), Carole Bourquin, Csaba Szabó, Reham M. Abdel‐Kader, Mohamed Z. Gad	12
4	GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Sébastien Fauteux‐Daniel, Pratyaksha Wirapati, (unknown), Jean‐Christophe Tille, Thomas McKee, Mikäel J. Pittet, Gaby Palmer, Carole Bourquin	1
5	Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review 2024 ·Non-Coding RNA ·R.A. Youness, (unknown), (unknown), (unknown), Alyaa Dawoud, (unknown), (unknown), Carole Bourquin, Reham M. Abdel‐Kader, Mohamed Z. Gad	12
6	2280P MiR-193a-3p: A pan-repressor of H2S synthesizing enzymes regulates tumorigenesis and immunosurveillance in breast cancer 2023 ·Annals of Oncology ·Alyaa Dawoud, R.A. Youness, (unknown), Carole Bourquin, Csaba Szabó, (unknown), Mohamed Z. Gad	2
7	Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells 2023 ·Antioxidants ·Sidnéia Sousa Santos, (unknown), Vanessa Martins, Maria Petrosino, Karim Zuhra, Kelly Ascenção, (unknown), Reham M. Abdel‐Kader, Mohamed Z. Gad, Carole Bourquin, Csaba Szabó	12
8	Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer 2023 ·OncoImmunology ·(unknown), (unknown), (unknown), Montserrat Alvarez, (unknown), (unknown), (unknown), (unknown), Eulàlia Olesti, (unknown), Víctor González‐Ruiz, Serge Rudaz, Jean‐Christophe Tille, (unknown), Patrycja Nowak‐Sliwinska, Carole Bourquin, Aurélien Pommier	8
9	Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study 2019 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), Inès Mottas, (unknown), Éric Allémann, Carole Bourquin, Florence Delié	30
10	Hook length of the bacterial flagellum is optimized for maximal stability of the flagellar bundle 2018 ·PLoS Biology ·(unknown), Vincent A. Martinez, C. Hotz, Jana Schwarz‐Linek, Keara L. Grady, (unknown), Teun Vissers, Hanna M. Singer, Manfred Rohde, Carole Bourquin, Haralampos Hatzikirou, Wilson C. K. Poon, Y. Dufour, Marc Erhardt	37
11	Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation 2017 ·International Journal of Pharmaceutics ·(unknown), (unknown), Inès Mottas, (unknown), Florence Delié, Éric Allémann, Carole Bourquin	51
12	Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression 2015 ·Cancer Research ·David Anz, Moritz Rapp, Stephan Eiber, Viktor H. Koelzer, Raffael Thaler, Sascha Haubner, Maximilian M. L. Knott, Sarah Nagel, Michaela Golić, Gabriela M. Wiedemann, Franz Bauernfeind, Cornelia Wurzenberger, Veit Hornung, Christoph Scholz, Doris Mayr, Simon Rothenfußer, Stefan Endres, Carole Bourquin	63
13	Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome Activation breakdown → 2013 ·Immunity ·Yiqing Yan, Wei Jiang, Thibaud Spinetti, Aubry Tardivel, Rosa Castillo, Carole Bourquin, Greta Guarda, Zhigang Tian, Jürg Tschopp, Rongbin Zhou	605
14	CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice 2011 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Nadja Sandholzer, Moritz Rapp, David Anz, Stefan Endres, Carole Bourquin	199
15	Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance 2011 ·Cancer Research ·Carole Bourquin, C. Hotz, Daniel Noerenberg, (unknown), Simon Heidegger, (unknown), Bettina Storch, Nadja Sandholzer, Cornelia Wurzenberger, David Anz, Stefan Endres	68
16	Selection of Molecular Structure and Delivery of RNA Oligonucleotides to Activate TLR7 versus TLR8 and to Induce High Amounts of IL-12p70 in Primary Human Monocytes 2009 ·The Journal of Immunology ·Andrea Ablasser, Hendrik Poeck, David Anz, Michael Berger, Martin Schlee, Sarah Kim-Hellmuth, Carole Bourquin, Nadège Goutagny, Zhaozhao Jiang, Katherine A. Fitzgerald, Simon Rothenfußer, Stefan Endres, Gunther Hartmann, Veit Hornung	83
17	Activation of Melanoma Differentiation-Associated Gene 5 Causes Rapid Involution of the Thymus 2009 ·The Journal of Immunology ·David Anz, Raffael Thaler, (unknown), Zoe Waibler, (unknown), Christoph Scholz, Ulrich Kalinke, Winfried Barchet, Stefan Endres, Carole Bourquin	32
18	Immunostimulatory RNA Blocks Suppression by Regulatory T Cells 2009 ·The Journal of Immunology ·David Anz, Viktor H. Koelzer, (unknown), Raffael Thaler, Tobias Schwerd, Katharina Lahl, Tim Sparwasser, Robert Besch, Hendrik Poeck, Veit Hornung, Gunther Hartmann, Simon Rothenfußer, Carole Bourquin, Stefan Endres	43
19	Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity 2008 ·The Journal of Immunology ·Carole Bourquin, David Anz, (unknown), Anna-Lisa Lanz, Sebastian Fuchs, (unknown), Cornelia Wurzenberger, Philip von der Borch, Michaela Golić, (unknown), Gerhard Winter, Conrad Coester, Stefan Endres	125
20	Selective Unresponsiveness to Conformational B Cell Epitopes of the Myelin Oligodendrocyte Glycoprotein in H-2b Mice 2003 ·The Journal of Immunology ·Carole Bourquin, Anna Schubart, (unknown), Ian H. Mather, Sherry Ogg, Roland Liblau, Christopher Linington	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact